Erythropoietin‐induced rheological changes of rat erythrocytes
- 1 July 2000
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 110 (1) , 82-88
- https://doi.org/10.1046/j.1365-2141.2000.02150.x
Abstract
The effects of recombinant human erythropoietin (rhEPO) on red blood cell (RBC) rheological properties were investigated in rats. Rats received intramuscular injections of 150 U/kg/d rhEPO for 5 d, following which blood samples were obtained 1, 5 or 10 d later. RBC deformability was assessed by determining cell transit times through 5-microm micropores (CTA) and RBC shape recovery time constants via photometry, aggregation in plasma and dextran was measured by photometry and RBC electrophoretic mobility was determined in a cylindrical electrophoresis system. RBC aggregation was found to be significantly decreased on day 5 after rhEPO treatment (P < 0.05), yet was unchanged from control on days 1 and 10. Mean RBC micropore transit times remained unchanged, but the distributions of transit times were altered; compared with control, the 5th percentiles on both days 1 and 5 were decreased and the 95th percentile on day 1 was elevated. Electrophoretic mobility of RBCs in phosphate-buffered saline was significantly increased on day 5 after rhEPO treatment (P < 0.05), with mobility measurements in dextran 500 (MW = 500 kDa) solutions suggesting that the cells' surface properties related to the formation of a 'depletion layer' may be altered on day 1. These results indicate that the rheological behaviour of RBC as a consequence of rhEPO treatment are temporal and are affected by the presence of reticulocytes as well as by the average age of the circulating cells.Keywords
This publication has 33 references indexed in Scilit:
- Deformability of red blood cells from different species studied by resistive pulse shape analysis techniqueBiorheology, 1996
- Erythropoietin Treatment Does Not Compromise Cardiovascular Function in Chronic Renal FailureAngiology, 1994
- Hemorheology and Fistula Function in Home Hemodialysis Patients following Erythropoietin Treatment: A Prospective Placebo-Controlled StudyNephron, 1993
- The influence of fractions of abnormal erythrocytes on aggregationEuropean Journal of Clinical Investigation, 1991
- Reduced Erythrocyte Deformability in Anemic Rats with Adjuvant ArthritisThe Japanese Journal of Pharmacology, 1990
- Erythrocyte rheologyCritical Reviews in Oncology/Hematology, 1990
- Rheological properties of erythrocytes in recombinant human erythropoietin‐administered normal ratBritish Journal of Haematology, 1989
- HYPERTENSION, BLOOD VISCOSITY, AND CARDIOVASCULAR MORBIDITY IN RENAL FAILURE: IMPLICATIONS OF ERYTHROPOIETIN THERAPYThe Lancet, 1988
- The maturational breakdown of mitochondria in reticulocytesBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1986
- Biochemical characterization of density-separated human erythrocytesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1976